Introducing the SubjectWell+ Platform
The SubjectWell+ Platform delivers the most comprehensive solutions for patient recruitment and site enablement, seamlessly paired with advanced commercial capabilities to connect patients with clinical trials and new treatments. Powered by a robust technology platform, a full suite of tailored services, creative expertise, and an extensive partner network, SubjectWell+ is backed by over 13 million motivated patients eager to participate in research that drives change.
It’s time for more. It’s time for SubjectWell+.
Innovative patient recruitment and commercial solutions
At SubjectWell, we collaborate with every key player in clinical research and commercial services to accelerate patient recruitment, improve site performance, optimize study outcomes, and drive market success. Whether you’re a sponsor, CRO, Site, Site Network, or Brand Marketers our tailored solutions meet your unique needs and deliver measurable results.
Explore how our specialized services empower your role in advancing healthcare breakthroughs and achieving commercial excellence.
It’s time to transform patient recruitment
The clinical trial landscape has changed dramatically. Protocols are more complex, patient needs have evolved, and regulatory standards are stricter. Globalization has made finding patients even more challenging. Yet, patient recruitment strategies have remained stagnant, leading to an 80% clinical trial failure rate and $40 billion in unrecoverable losses.
-
30%
Accelerate enrollment by
$40B
Recoup $40B in losses
13M+
patients in our network
-
47%
of patients identify as people of color
1,400+
studies completed
15,500+
sites served
-
100+
clinically trained patient companions
22
languages supported in our Companion Centers
Expertise across all therapeutic areas
-
AI/ML tools to reach the hardest-to-find patients
Seamless CTMS integrations
Real-time feedback for sponsors, sites, and CROs
Global recruitment for every Therapeutic Area
Rare, Complex, or Chronic Conditions
SubjectWell is your partner for patient recruitment across every therapeutic area, anywhere in the world. From rare disease and oncology to chronic conditions and vaccine studies, our expertise ensures your study’s success. With over 13 million patients in our marketplace, we’ve supported more than 500,000 patient referrals across 15,000 sites, delivering measurable results for sponsors and studies worldwide.

Building trust. Improving retention. Enhancing outcomes.
Clinical trials require trust and understanding as patients make significant sacrifices and navigate difficult decisions. At the same time, sites face increasing challenges such as administrative tasks, resource constraints, and data management burdens, all of which can detract from patient care and contribute to recruitment failures.
SubjectWell bridges these gaps with comprehensive solutions that ensure that patients stay informed, engaged, and valued throughout the recruitment and clinical development process while reducing both patient and site burden.
Insights from industry leaders
Stay informed with expert insights on clinical trial trends, patient recruitment strategies,
and healthcare innovations.
-
Bridging the Gap: Why Diversity Action Plans Are Critical in Clinical Trials
With the FDA’s Diversity Action Plan taking effect in July 2025, clinical trials must move beyond15 Jan 2025●6 min -
New FMLA Guidance Empowers Patients to Participate in Clinical Trials
New FMLA guidance now protects job security for patients participating in clinical trials, removing22 Nov 2024●3 min -
How to Prepare for FDA-Mandated Clinical Diversity Action Plans (DAPs)
Understanding FDA’s Guidance on Diversity Action Plans (DAPs) is vital for health equity in08 Nov 2024●4 min -
How Medical Contact Centers Power Patient Recruitment for Clinical Trials
Patient recruitment is one of the most critical and challenging aspects of clinical trials. Medical09 Jul 2024●3 min
Get started with SubjectWell
Join 3,000+ customers leveraging SubjectWell to accelerate clinical trial recruitment, engage patients, and drive study success. Let’s revolutionize research together.